Lonnie Bookbinder

Lonnie Bookbinder, MBA, PhD, is a seasoned entrepreneur and executive in the biotechnology and precision medicine sectors. As the Founder, Founding CEO, and Chairman of the Board of Directors at ARIZ Precision Medicine since January 2015, Lonnie leads efforts to address cancer at its genetic root, with a focus on a lead drug candidate in lung cancer studies. Lonnie also founded and serves as CEO of Medical Marketing & Management, providing strategic consultation for diagnostic and therapeutic companies since 1983. With a history of co-founding SEngine Precision Medicine, and holding leadership roles in various organizations such as Calvert Labs & Research, Ribi ImmunoChem, Nycomed-Salutar, Immunomedics, and Lederle Labs, Lonnie has extensive experience in business development, corporate strategy, and fostering innovation in emerging biotechnologies. Educational qualifications include a BS in Molecular Biology, an MBA in Biotechnology Business Management, and a PhD in Capital Formation and Investment in the Biotechnology Industry.